Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
Molecular Cancer · 08.05.2024 · 23 (1)
DOI: 10.1186/s12943-024-02001-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cancer, online erschienen am 08.05.2024. Verfasst von Ying Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan U…. Hauptthemen laut MEDLINE: B-Lymphocytes, Carcinoma, Hepatocellular, Fatty Liver, Immunoglobulin A. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, 111 Project.
Abstract (Originalsprache)
Background
Dysregulation of immune surveillance is tightly linked to the development of metabolic dysfunction-associated steatohepatitis (MASH)-driven hepatocellular carcinoma (HCC); however, its underlying mechanisms remain unclear. Herein, we aimed to determine the role of interleukin-21 receptor (IL-21R) in MASH-driven HCC.
Methods
The clinical significance of IL-21R was assessed in human HCC specimens using immunohistochemistry staining. Furthermore, the expression of IL-21R in mice was assessed in the STAM model. Thereafter, two different MASH-driven HCC mouse models were applied between IL-21R-deficient mice and wild type controls to explore the role of IL-21R in MASH-driven HCC. To further elucidate the potential mechanisms by which IL-21R affected MASH-driven HCC, whole transcriptome sequencing, flow cytometry and adoptive lymphocyte transfer were performed. Finally, flow cytometry, enzyme-linked immunosorbent assay, immunofluorescent staining, chromatin immunoprecipitation assay and western blotting were conducted to explore the mechanism by which IL-21R induced IgA + B cells.
Results
HCC patients with high IL-21R expression exhibited poor relapse-free survival, advanced TNM stage and severe steatosis. Additionally, IL-21R was demonstrated to be upregulated in mouse liver tumors. Particularly, ablation of IL-21R impeded MASH-driven hepatocarcinogenesis with dramatically reduction of lipid accumulation. Moreover, cytotoxic CD8 + T lymphocyte activation was enhanced in the absence of IL-21R due to the reduction of immunosuppressive IgA + B cells. Mechanistically, the IL-21R-STAT1-c-Jun/c-Fos regulatory axis was activated in MASH-driven HCC and thus promoted the transcription of Igha , resulting in the induction of IgA + B cells.
Conclusions
IL-21R plays a cancer-promoting role by inducing IgA + B cells in MASH-driven hepatocarcinogenesis. Targeting IL-21R signaling represents a potential therapeutic strategy for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China.
- Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated With Jinan University, Jinan University, Zhuhai, 51900…
- Department of Pathology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510632, China.
- The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China. tzhinan@jnu.edu.cn.
- The Biomedical Translational Research Institute, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China. seta1988@126.com.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- 111 Project
- Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program
- Pearl River S & T Nova Program of Guangzhou, China
Zitieren
APA
Xie, Y., Huang, Y., Li, Z. Y., Jiang, W., Shi, N. X., Lu, Y., Cao, G., Yin, Z., & Lin, X. J. (2024). Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells. Molecular Cancer, 23(1). https://doi.org/10.1186/s12943-024-02001-2
Vancouver
Xie Y, Huang Y, Li ZY, Jiang W, Shi NX, Lu Y, et al. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells. Molecular Cancer. 2024;23(1). doi:10.1186/s12943-024-02001-2
BibTeX
@article{Xie2024,
author = {Xie, Ying and Huang, Yu and Li, Zhi-Yong and Jiang, Weihua and Shi, Nan-Xi and Lu, Yuanzhi and Cao, Guangchao and Yin, Zhinan and Lin, Xue-Jia},
title = {Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells},
journal = {Molecular Cancer},
year = {2024},
volume = {23},
number = {1},
doi = {10.1186/s12943-024-02001-2}
}
EUVIMED